ERBB2 and neoplasm: It is usually classified according to gene expression profiling of the tumor (PAM 50 assay) into 5 molecular subtypes correlated with prognosis and response to treatments: luminal A, luminal B, basal-like, HER2 positive, and normal-like [35, 36].